Read full article: https://www.inmunotek.com.au/feno
Asthma: It's about inflammation
It's now understood that up to 84% of asthma patients have Type 2 airway inflammation, which is particularly associated with exacerbations.1
FeNO: Inflammatory biomarker
Type 2 inflammation is driven by T-helper 2 cells, which produce interleukins IL-4, IL-5 and IL-13. IL-4 and IL-13 upregulate nitric oxide levels in the lungs.2
Your flare-up risk predictor
Elevated FeNO values are associated with 3.2x greater risk of exacerbations when compared to low FeNO levels.3
Biomarkers
Looking to the future of asthma management
As knowledge of the underlying causes of asthma has evolved, diagnostic and management methods have too.
Biomarkers provide objective data on biologic parameters such as airway inflammation and disease activity. This can improve the understanding of asthma and lead to better patient outcomes.
FeNO: The most convenient biomarker
Assess airway inflammation at the point of care
Accurate
As patients inhale, ambient Nitric Oxide, bacteria, viruses and excess humidity are removed from the breath, ensuring the exhalation reflects their true FeNO level
Reliable
The device of choice
NIOX® is trusted around the world by clinical researchers and healthcare professionals alike, used in thousands of trials across the globe.
Straightforward
What's my number today, doctor?
One test, one number. Airway inflammation in a single FeNO level.
-160x160-state_article-rel-cat.png)
